These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36056913)

  • 41. Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043).
    Liu F; Qiu B; Xi Y; Luo Y; Luo Q; Wu Y; Chen N; Zhou R; Guo J; Wu Q; Xiong M; Liu H
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):433-443. PubMed ID: 35870709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
    Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
    Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
    Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
    J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity.
    Matteucci C; Nepravishta R; Argaw-Denboba A; Mandaliti W; Giovinazzo A; Petrone V; Balestrieri E; Sinibaldi-Vallebona P; Pica F; Paci M; Garaci E
    Int Immunopharmacol; 2023 May; 118():110113. PubMed ID: 37028279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits.
    Chen Y; Wang A; Zhao L; Shen G; Cui L; Tang K
    Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):303-12. PubMed ID: 18752465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients.
    Bersanelli M; Giannarelli D; Leonetti A; Buti S; Tiseo M; Nouvenne A; Ticinesi A; Meschi T; Procopio G; Danielli R
    Future Oncol; 2021 Mar; 17(9):1097-1104. PubMed ID: 33538178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thymosin alpha in the treatment of chronic hepatitis B: an uncontrolled open-label trial.
    Amarapurkar D; Das HS
    Indian J Gastroenterol; 2002; 21(2):59-61. PubMed ID: 11990327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
    Lao X; Liu M; Chen J; Zheng H
    PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymosin alpha 1 as an adjuvant to hyperthermic intraperitoneal chemotherapy in an experimental model of peritoneal metastases from colonic carcinoma.
    Nevo N; Lee Goldstein A; Bar-David S; Natanson M; Alon G; Lahat G; Nizri E
    Int Immunopharmacol; 2022 Oct; 111():109166. PubMed ID: 35994852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
    Lau GK
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
    Hadden JW; Verastegui E; Hadden E
    Ann N Y Acad Sci; 2007 Sep; 1112():245-55. PubMed ID: 17600288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fusion of thymosin alpha 1 with mutant IgG1 CH3 prolongs half-life and enhances antitumor effects in vivo.
    Shen X; Wang L; Xu C; Yang J; Peng R; Hu X; Wang F; Zheng H; Lao X
    Int Immunopharmacol; 2019 Sep; 74():105662. PubMed ID: 31220695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial.
    Andreone P; Gramenzi A; Cursaro C; Felline F; Loggi E; D'Errico A; Spinosa M; Lorenzini S; Biselli M; Bernardi M
    J Viral Hepat; 2004 Jan; 11(1):69-73. PubMed ID: 14738560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High expression of thymosin alpha 1 by injecting recombinant PVX vector into the tomato fruit].
    Ni Y; Shi Z; Wang D; Yao M; Qiao M; Guo P
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):537-41. PubMed ID: 19637628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats.
    Moody TW; Tuthill C; Badamchian M; Goldstein AL
    Peptides; 2002 May; 23(5):1011-4. PubMed ID: 12084534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.
    Ohmori H; Kamo M; Yamakoshi K; Nitta MH; Hikida M; Kanayama N
    Immunopharmacol Immunotoxicol; 2001 Feb; 23(1):75-82. PubMed ID: 11322651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thymosin in the early diagnosis and treatment of high risk homosexuals and hemophiliacs with AIDS-like immune dysfunction.
    Naylor PH; Schulof RS; Sztein MB; Spira TJ; McCurdy PR; Darr F; Kessler CM; Simon GL; Goldstein AL
    Ann N Y Acad Sci; 1984; 437():88-99. PubMed ID: 6398657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thymosin alpha1 is a time and dose-dependent antagonist of dexamethasone-induced apoptosis of murine thymocytes in vitro.
    Baumann CA; Badamchian M; Goldstein AL
    Int J Immunopharmacol; 2000 Dec; 22(12):1057-66. PubMed ID: 11137612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
    Yang YF; Zhao W; Zhong YD; Yang YJ; Shen L; Zhang N; Huang P
    Antiviral Res; 2008 Feb; 77(2):136-41. PubMed ID: 18078676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
    Cheng LL; Guan WJ; Duan CY; Zhang NF; Lei CL; Hu Y; Chen AL; Li SY; Zhuo C; Deng XL; Cheng FJ; Gao Y; Zhang JH; Xie JX; Peng H; Li YX; Wu XX; Liu W; Peng H; Wang J; Xiao GM; Chen PY; Wang CY; Yang ZF; Zhao JC; Zhong NS
    JAMA Intern Med; 2021 Jan; 181(1):71-78. PubMed ID: 32910179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.